Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Muscle Weakness 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Brain Neoplasms 1

Interventions

enzalutamide 16Magnetic Resonance Spectroscopy 16apalutamide 15Prednisone 12Androgen Antagonists 12Abiraterone Acetate 12Specimen Handling 11darolutamide 7abiraterone 7Radiotherapy 7Pluvicto 6Nivolumab 6Docetaxel 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6cabazitaxel 5Radiosurgery 5Lutetium-177 5Biopsy 5radium Ra 223 dichloride 4cabozantinib 4bicalutamide 4atezolizumab 4Standard of Care 4Lutetium 4olaparib 3gallium 68 PSMA-11 3Watchful Waiting 3Surveys and Questionnaires 3Radiotherapy, Intensity-Modulated 3Fulvestrant 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Positron-Emission Tomography × 30 days × Clear all
NCT05470699 2026-06-02

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

City of Hope Medical Center

Phase NA Active not recruiting
34 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT05477823 2026-06-02

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

University of Wisconsin, Madison

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡